The risk of cardiovascular events in patients with resistant hypertension

被引：0
|
作者：
Yuan, Zhong [1 ]
Swerdel, Joel N. [2 ]
Ryan, Patrick B. [3 ]
Osokogu, Osemeke [4 ]
Saran, Sukhdev K. [1 ]
Haskell, Lloyd [1 ]
机构：
[1] Janssen R&D, Beerse, Belgium
[2] Janssen Pharmaceut Inc, Beerse, Belgium
[3] Johnson & Johnson, New Brunswick, NJ USA
[4] Janssen Global Med Safety, High Wycombe, Bucks, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
499
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [31] Clinical Question: Can CPAP suppress cardiovascular events in resistant hypertension patients with obstructive sleep apnea?
    Osanai, Shinobu
    HYPERTENSION RESEARCH, 2023, 46 (06) : 1606 - 1608
  • [32] Systolic Blood Pressure and Pulse Pressure Are Predictors of Future Cardiovascular Events in Patients with True Resistant Hypertension
    Mesquita Bastos, J.
    Ferraz, Lisa
    Pereira, Flavio G.
    Lopes, Susana
    DIAGNOSTICS, 2023, 13 (10)
  • [33] Sodium sensitivity and cardiovascular events in patients with essential hypertension
    Morimoto, A
    Uzu, T
    Fujii, T
    Nishimura, M
    Kuroda, S
    Nakamura, S
    Inenaga, T
    Kimura, G
    LANCET, 1997, 350 (9093): : 1734 - 1737
  • [34] Association of alprazolam with major cardiovascular events in patients with hypertension
    Yeh, Chao-Bin
    Tsai, Ming-Che
    Teng, Ying-Hock
    Ku, Min-Sho
    Huang, Jing-Yang
    Wang, Bo-Yuan
    Tai, Chia-Ling
    Kornelius, Edy
    Ho, Sai-Wai
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (03) : 983 - 991
  • [35] RESISTANT HYPERTENSION AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERTENSIVE CRISES AFTER 12-MONTH FOLLOW-UP: A GREEK REGISTRY
    Fragoulis, Christos
    Thomopoulos, Costas
    Polyzos, Dimitrios
    Mavroudis, Andreas
    Tsioufis, Panagiotis
    Leontsinis, Ioannis
    Sakalidis, Athanasios
    Mantzouranis, Emmanouil
    Kouremeti, Maria
    Drogkaris, Sotirios
    Tatakis, Fotis
    Kachrimanidis, Ioannis
    Vlachakis, Panayotis K.
    Manta, Eleni
    Siafi, Eirini
    Dimitriadis, Kyriakos
    Konstantinidis, Dimitrios
    Tsioufis, Konstantinos
    JOURNAL OF HYPERTENSION, 2023, 41 : E294 - E294
  • [36] Calcium antagonists and cardiovascular events in patients with hypertension and diabetes
    Alderman, M
    Madhavan, S
    Cohen, H
    LANCET, 1998, 351 (9097): : 216 - 217
  • [37] Body build and risk of cardiovascular events in hypertension: The LIFE Study
    de Simone, G
    Wachtel, K
    Palmieri, V
    Beavers, G
    Dahlof, B
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kjeldsen, SE
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, P
    Oparil, S
    Hille, DA
    Devereux, RB
    CIRCULATION, 2004, 110 (17) : 771 - 771
  • [38] Body build and risk of cardiovascular events in hypertension:: The life study
    de Simone, G
    Wachtell, K
    Palmieri, V
    Beevers, G
    Dahlöf, B
    de Faire, U
    Fyhrquist, F
    Ibsen, H
    Kjeldsen, SE
    Lederballe-Pedersen, O
    Lindholm, LH
    Nieminen, MS
    Omvik, R
    Oparil, S
    Hille, DA
    JOURNAL OF HYPERTENSION, 2005, 23 : S133 - S133
  • [39] Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
    Mehlum, Maria H.
    Liestol, Knut
    Kjeldsen, Sverre E.
    Julius, Stevo
    Hua, Tsushung A.
    Rothwell, Peter M.
    Mancia, Giuseppe
    Parati, Gianfranco
    Weber, Michael A.
    Berge, Eivind
    EUROPEAN HEART JOURNAL, 2018, 39 (24) : 2243 - 2251
  • [40] Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network
    Mancusi, Costantino
    Losi, Maria A.
    Izzo, Raffaele
    Canciello, Grazia
    Carlino, Maria V.
    Albano, Giovanni
    De Luca, Nicola
    Trimarco, Bruno
    de Simone, Giovanni
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (03) : 235 - 243
12345